Mateo-Montoya Aránzazu, Mendrinos Efstratios, Tabatabay Cyrus, Pournaras Constantin J
Ophthalmology Clinic, Department of Clinical Neurosciences, Geneva University Hospital, Geneva, Switzerland.
Semin Ophthalmol. 2011 Mar;26(2):37-41. doi: 10.3109/08820538.2010.544236.
To report results and complications of 23-gauge transconjunctival sutureless pars plana vitrectomy for a variety of vitreoretinal diseases.
A prospective consecutive case series study was performed in 66 eyes of 66 patients. Indications for surgery were epiretinal membrane (n = 20), rhegmatogenous retinal detachment (n = 19: 14 pseudophakic, 5 phakic), macular hole (n = 16), vitreous hemorrhage (n = 5), cyclodialysis (n = 1), intraocular lens luxation (n = 1), asteroid hyalosis (n = 1), congenital retinoschisis (n = 1), and endophtalmitis (n = 2). Main outcome measures included visual acuity, intraocular pressure, and intra- and post-operative complications.
Mean patient age at time of operation was 68 ± 12 years. Overall, visual acuity improved from 1.03 ± 1.00 logMAR preoperatively to 0.32 ± 0.33 logMAR postoperatively (p < 0.01) after a mean follow-up time of 9.3 ± 4.7 months. Mean preoperative intraocular pressure was 13.9 ± 3.5 mmHg, and mean postoperative intraocular pressure was 17.9 ± 9.6 mmHg on day 1 (p < 0.01) and 14.7 ± 2.8 mmHg (p = 0.05) at final visit. Concerning complications, 2 cases of hypotony and 7 of hypertony occurred on day 1, a macular hole reopened some weeks later, and a retinal detachment recurred in one case.
23-gauge transconjunctival sutureless vitrectomy is an effective and safe technique for a variety of vitreoretinal diseases.
报告23G经结膜无缝合平坦部玻璃体切除术治疗各种玻璃体视网膜疾病的结果及并发症。
对66例患者的66只眼进行前瞻性连续病例系列研究。手术适应证包括视网膜前膜（n = 20）、孔源性视网膜脱离（n = 19：14只人工晶状体眼，5只晶状体眼）、黄斑裂孔（n = 16）、玻璃体积血（n = 5）、睫状体脱离（n = 1）、人工晶状体脱位（n = 1）、星状玻璃体病变（n = 1）、先天性视网膜劈裂（n = 1）和眼内炎（n = 2）。主要观察指标包括视力、眼压以及手术中和术后并发症。
手术时患者的平均年龄为68±12岁。总体而言，平均随访9.3±4.7个月后，视力从术前的1.03±1.00 logMAR提高到术后的0.32±0.33 logMAR（p < 0.01）。术前平均眼压为13.9±3.5 mmHg，术后第1天平均眼压为17.9±9.6 mmHg（p < 0.01），末次随访时为14.7±2.8 mmHg（p = 0.05）。关于并发症，术后第1天发生2例低眼压和7例高眼压，数周后1例黄斑裂孔复发，1例视网膜脱离复发。
23G经结膜无缝合玻璃体切除术是治疗各种玻璃体视网膜疾病的一种有效且安全的技术。
